Experiments with rodent crescentic GN models suggested that CD4+ T cells, particularly Th17 cells, promote GN disease progression through the production of related cytokines, such as IL-17A, IL-17F, and IFN-γ. This evidence concerns the gene IL17A and ganglioneuroma.